Table 1.
Euthanized at day 29 |
Euthanized at day 43 |
|||||
H1PV dose (pfu) | Hematology Clinical biochemistry Urinalysis Histopathology | RT-PCR | Toxicokinetics | Hematology Clinical biochemistry Urinalysis Histopathology | Hematology Clinical biochemistry Urinalysis RT-PCR | |
Vehiclea | 0 | 10 male | 5 male | 5 male | 7 maleb | 5 male |
10 female | 5 female | 5 female | 6 femaleb | 5 female | ||
Ringer | 0 | 5 male | none | none | 5 male | none |
5 female | none | none | 5 female | none | ||
H1PV | 106 | 10 male | 5 male | 5 male | none | none |
10 female | 5 female | 5 female | none | none | ||
H1PV | 107 | 10 male | 5 male | 5 male | none | none |
10 female | 5 female | 5 female | none | none | ||
H1PV | 108 | 10 male | 5 male | 5 male | 5 male | 5 male |
10 female | 5 female | 5 female | 5 female | 5 female |
All rats received 750 µL per injection.
The vehicle comprised 10% iodixanol in Ringer solution
2 additional male and one additional female rats were included, because 3 animals had to be euthanized prematurely (2 at day 15 and 1 at day 18) due to deteriorated health status unrelated to the vehicle administration. These additional animals were handled according to the same protocol as for the other rats in this group and received a total of 17 injections over 28 d.